{
  "id": 9742461,
  "title": "After capital-markets day flop, Novo strikes licensing deal that sends a Swedish company’s stock soaring",
  "url": "https://urgent.news/2026/09/25/after-capital-markets-day-flop-novo-strikes-licensing-deal-that-sends",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-25T09:11:00.000Z",
  "source": {
    "name": "MarketWatch",
    "slug": "marketwatch",
    "url": "https://www.marketwatch.com/story/after-capital-markets-day-flop-novo-strikes-licensing-deal-that-sends-a-swedish-companys-stock-soaring-f3c99cbe?mod=mw_rss_topstories"
  },
  "original_language": "en",
  "account": null,
  "summary": "Just days after a capital-markets day left investors wondering what’s next for Novo Nordisk, the Danish drug giant struck a licensing deal worth over $1 billion.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "MarketWatch Top",
        "title": "After capital-markets day flop, Novo strikes licensing deal that sends a Swedish company’s stock soaring",
        "url": "https://urgent.news/2026/09/25/after-capital-markets-day-flop-novo-strikes-licensing-deal-that-sends-9747208",
        "published": "2026-09-25T09:11:00.000Z"
      },
      {
        "outlet": "CNBC World",
        "title": "Pharma stock soars 150% on injectables deal with Wegovy maker Novo",
        "url": "https://urgent.news/2026/09/25/pharma-stock-soars-150-on-injectables-deal-with-wegovy-maker-novo",
        "published": "2026-09-25T09:58:27.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}